Inflammatory bowel disease (IBD) is a chronic systemic inflammatory condition. Previously,
the focus has been on extraintestinal manifestations of IBD, including arthritis, psoriasis, and …

Patients with inflammatory bowel disease (IBD) have an increased risk of vascular
complications. Thromboembolic complications, both venous and arterial, are serious …

Inflammatory bowel diseases (IBDs) consist of a group of chronic inflammatory disorders
with a complex etiology, which represent a clinical challenge due to their often therapy …

Inflammatory bowel disease affects more than 2 million people in Europe, with almost 20%
of patients being diagnosed in pediatric age. Patients with inflammatory bowel disease are …

A link between colitis and colon cancer is well established, but the mechanisms regulating
inflammation in this context are not fully defined. Given substantial evidence that hemostatic …

The gastrointestinal tract (GIT) is a metabolically significant site of sulfur amino acid (SAA)
metabolism in the body and metabolises about 20% of the dietary methionine intake which …

Extraintestinal manifestations of inflammatory bowel disease (IBD) are a systemic illness that
may affect up to half of all patients. Among the extraintestinal manifestations of IBD, those …

Enteropathic arthritis (EA) is a spondyloarthritis (SpA) which occurs in patients with
inflammatory bowel diseases (IBDs) and other gastrointestinal diseases. Diagnosis is …

Patients with inflammatory bowel disease (IBD) may have an increased risk of venous
thrombosis (VTE). PubMed, ISI Web of Knowledge and Scopus were searched to identify …

Recent findings indicate that dextran sodium sulfate (DSS)-induced colitis is associated with
a prothrombogenic phenotype, with P-selectin playing a major role in platelet recruitment. It …